» Articles » PMID: 38055379

Multidrug-resistant Tuberculous Orchiepididymitis: a Brief Case Report

Overview
Specialty Tropical Medicine
Date 2023 Dec 6
PMID 38055379
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberculosis (TB) is one of the leading causes of death by infectious diseases worldwide. Multidrug-resistant tuberculosis is a growing problem, especially in countries with high TB prevalence. Although the lungs are the organs most frequently affected by this disease, Mycobacterium tuberculosis can harm any organ, including the urogenital tract, causing extrapulmonary tuberculosis, which leads to a challenging diagnosis and consequent treatment delays. In this article, we present a case of orchiepididymitis caused by multidrug-resistant TB (MDR-TB) with a significantly delayed diagnosis, the proposed treatment according to the resistance profile, and the clinical outcomes.

References
1.
Bartholomay P, Pinheiro R, Dockhorn F, Pelissari D, de Araujo W . Brazilian cohort study of risk factors associated with unsuccessful outcomes of drug resistant tuberculosis. BMC Infect Dis. 2021; 21(1):1049. PMC: 8502313. DOI: 10.1186/s12879-021-06756-7. View

2.
Silva D, Menegotto D, Schulz L, Gazzana M, Dalcin P . Clinical characteristics and evolution of non-HIV-infected immunocompromised patients with an in-hospital diagnosis of tuberculosis. J Bras Pneumol. 2010; 36(4):475-84. DOI: 10.1590/s1806-37132010000400013. View

3.
Williams M, Burris A, Zingalis A, Lindholm D, White B . Disseminated Tuberculosis Presenting as Chronic Orchiepididymitis in a Military Trainee: A Case Report and Review of the Literature. Case Rep Infect Dis. 2018; 2018:7316097. PMC: 6192136. DOI: 10.1155/2018/7316097. View

4.
Arega B, Mersha A, Minda A, Getachew Y, Sitotaw A, Gebeyehu T . Epidemiology and the diagnostic challenge of extra-pulmonary tuberculosis in a teaching hospital in Ethiopia. PLoS One. 2020; 15(12):e0243945. PMC: 7737896. DOI: 10.1371/journal.pone.0243945. View

5.
Xi Y, Zhang W, Qiao R, Tang J . Risk factors for multidrug-resistant tuberculosis: A worldwide systematic review and meta-analysis. PLoS One. 2022; 17(6):e0270003. PMC: 9202901. DOI: 10.1371/journal.pone.0270003. View